Hamill John P. bought APRE
March 12, 2026 · Form 4 insider transaction
Hamill John P. bought 10,095 shares of Aprea Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
10,095
Price
$0.00
Total value
N/A
InsiderHamill John P.
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMarch 12, 2026
Filing dateMarch 16, 2026
Shares owned after43,528
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These shares represent restricted stock units and shall vest and be settled in the Issuer's common stock in three (3) equal annual installments beginning on March 12, 2027, until vested in full, subject to the reporting person's continued employment through and including the applicable vesting dates and subject to acceleration under certain conditions.